2020 Annual Meeting | C243 - Core Principles of Brain Tumors

Date Thursday 04/30/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Nimish A. Mohile, MD, FAAN

Topic(s) Neuro-oncology

Learning Objectives Participants should improve their knowledge of the management of common primary and metastatic brain tumors, develop an improved understanding of neurologic care and supportive care of the brain tumor patient, and better understand the role of different providers in a mutl-disciplinary care team.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
03:30 PM - 03:40 PM	Speaker	Overview of Classification of Brain Tumors Nimish A. Mohile, MD, FAAN
03:40 PM - 04:00 PM	Speaker	A Primer on Malignant Gliomas Jennie W. Taylor, MD
04:00 PM - 04:20 PM	Speaker	Low Grade Gliomas and Beyond Sylvia C. Kurz, MD, PhD
04:20 PM - 04:35 PM	Discussion	How Does a Neurology Care Team Optimize Care for Patients with Primary Brain Tumors?
04:35 PM - 04:55 PM	Speaker	CNS Metastases for the Neurologist Rimas V. Lukas, MD
04:55 PM - 05:15 PM	Speaker	Central Nervous System Lymphomas Nimish A. Mohile, MD, FAAN
05:15 PM - 05:30 PM	Discussion	Models of Multi-Disciplinary Care

Faculty Disclosures
Nimish A. Mohile, MD, FAAN	The institution of Dr. Mohile has received research support from Novocure.
Rimas V. Lukas, MD	Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Lukas has received research support from BMS. The institution of Dr. Lukas has received research support from BrainUp. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from Ziopharm.
Jennie W. Taylor, MD	Dr. Taylor has received personal compensation for serving as an employee of Servier. The institution of Dr. Taylor has received research support from BMS. The institution of Dr. Taylor has received research support from Servier. The institution of Dr. Taylor has received research support from Navio. Dr. Taylor has received research support from University of Colorado. Dr. Taylor has received research support from Mt Sinai University . Dr. Taylor has received publishing royalties from a publication relating to health care.
Sylvia C. Kurz, MD, PhD	Dr. Kurz has received personal compensation in the range of $0-$499 for serving as a Consultant for Advanced Accelerator Applications.

��ɫ��

��ɫ��